13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q3 2024 · Filed November 15, 2024 · Accession 0001892134-24-000006
Total Value
$2.50B
Positions
53
Other Managers
0
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIRUM PHARMACEUTICALS INC | MIRM | 6,570,392 | $256.2M | 10.27% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 12,855,194 | $213.4M | 8.55% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $182.8M | 7.33% |
| 4 | KRYSTAL BIOTECH INC | KRYS | 988,460 | $179.9M | 7.21% |
| 5 | MBX BIOSCIENCES INC | MBX | 5,985,347 | $155.5M | 6.23% |
| 6 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,416,952 | $126.6M | 5.08% |
| 7 | VAXCYTE INC | PCVX | 879,405 | $100.5M | 4.03% |
| 8 | VERONA PHARMA PLC | 925050106 | 3,383,950 | $97.4M | 3.90% |
| 9 | BRIDGEBIO PHARMA INC | BBIO | 3,760,457 | $95.7M | 3.84% |
| 10 | DISC MEDICINE INC | IRON | 1,754,834 | $86.2M | 3.46% |
| 11 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,785,284 | $81.7M | 3.27% |
| 12 | EDGEWISE THERAPEUTICS INC | EWTX | 2,832,867 | $75.6M | 3.03% |
| 13 | ANAPTYSBIO INC | ANABV | 2,209,189 | $74.0M | 2.97% |
| 14 | ERASCA INC | ERAS | 19,391,687 | $52.9M | 2.12% |
| 15 | TARSUS PHARMACEUTICALS INC | TARS | 1,587,527 | $52.2M | 2.09% |
| 16 | AGIOS PHARMACEUTICALS INC | AGIO | 1,044,154 | $46.4M | 1.86% |
| 17 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $45.2M | 1.81% |
| 18 | SOLENO THERAPEUTICS INC | SLNO | 875,667 | $44.2M | 1.77% |
| 19 | KALVISTA PHARMACEUTICALS INC | KALV | 3,687,867 | $42.7M | 1.71% |
| 20 | ORIC PHARMACEUTICALS INC | ORIC | 4,142,855 | $42.5M | 1.70% |
| 21 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 633,715 | $35.2M | 1.41% |
| 22 | SAVARA INC | SVRA | 8,157,385 | $34.6M | 1.39% |
| 23 | CG ONCOLOGY INC | CGON | 770,000 | $29.1M | 1.16% |
| 24 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,485,630 | $27.4M | 1.10% |
| 25 | TREVI THERAPEUTICS INC | TRVI | 7,381,090 | $24.7M | 0.99% |
| 26 | MEREO BIOPHARMA GROUP PLC | MREO | 5,097,779 | $21.0M | 0.84% |
| 27 | SILENCE THERAPEUTICS PLC | SLNCF | 1,148,591 | $20.9M | 0.84% |
| 28 | ASCENDIS PHARMA A/S | ASND | 133,333 | $19.9M | 0.80% |
| 29 | HILLEVAX INC | 43157M102 | 10,617,062 | $18.7M | 0.75% |
| 30 | MERUS N V | N5749R100 | 373,100 | $18.6M | 0.75% |
| 31 | TYRA BIOSCIENCES INC | TYRA | 731,020 | $17.2M | 0.69% |
| 32 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $16.8M | 0.67% |
| 33 | ALKERMES PLC | ALKS | 576,129 | $16.1M | 0.65% |
| 34 | IMMATICS N.V | IMTX | 1,354,711 | $15.5M | 0.62% |
| 35 | ORUKA THERAPEUTICS INC | ORKA | 477,327 | $11.7M | 0.47% |
| 36 | LEXEO THERAPEUTICS INC | LXEO | 1,250,786 | $11.3M | 0.45% |
| 37 | DESIGN THERAPEUTICS INC | DSGN | 1,892,547 | $10.2M | 0.41% |
| 38 | COGENT BIOSCIENCES INC | COGT | 936,576 | $10.1M | 0.41% |
| 39 | MACROGENICS INC | MGNX | 3,010,727 | $9.9M | 0.40% |
| 40 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 689,655 | $9.6M | 0.39% |
| 41 | ALLOGENE THERAPEUTICS INC | ALLO | 2,867,750 | $8.0M | 0.32% |
| 42 | PUMA BIOTECHNOLOGY INC | PBYI | 3,062,558 | $7.8M | 0.31% |
| 43 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,069,244 | $7.5M | 0.30% |
| 44 | 89BIO INC | 282559103 | 1,000,000 | $7.4M | 0.30% |
| 45 | ACADIA PHARMACEUTICALS INC | ACAD | 470,338 | $7.2M | 0.29% |
| 46 | ARVINAS INC | ARVN | 285,331 | $7.0M | 0.28% |
| 47 | PEPGEN INC | PEPG | 702,694 | $6.0M | 0.24% |
| 48 | ELEVATION ONCOLOGY INC | 28623U101 | 5,993,579 | $3.6M | 0.14% |
| 49 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $3.5M | 0.14% |
| 50 | IMMUNOCORE HLDGS PLC | IMCR | 108,762 | $3.4M | 0.14% |
| 51 | NUVATION BIO INC | NUVB | 1,218,236 | $2.8M | 0.11% |
| 52 | ACLARIS THERAPEUTICS INC | ACRS | 264,377 | $304,034 | 0.01% |
| 53 | PIERIS PHARMACEUTICALS INC | 720795202 | 15,942 | $266,869 | 0.01% |